A prediction model and risk stratification tool for survival by chemotherapy in invasive micropapillary carcinoma of the breast: a population-based study with external validation - Scorecard - MDSpire
Advertisement
A prediction model and risk stratification tool for survival by chemotherapy in invasive micropapillary carcinoma of the breast: a population-based study with external validation
Clinical Scorecard: Development of a Survival Prediction Model and Risk Assessment Tool for Chemotherapy in Invasive Micropapillary Carcinoma of the Breast: Insights from a Population-Based Study with External Validation
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Female patients aged ≥18 years with histologically confirmed IMPC, excluding those with distant metastasis.
Care Setting
Key Highlights
Risk model developed to stratify patients based on marital status, tumor size, subtype, and radiotherapy history, aiding in personalized treatment decisions.
Guideline-Based Recommendations
Diagnosis
Management
Consider chemotherapy primarily for high-risk IMPC patients, assessing clinical factors such as tumor grade and receptor status.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Chemotherapy improves OS in high-risk patients but not in low-risk patients; consider potential side effects.
Clinical Best Practices
Utilize a risk stratification model for treatment decisions.
Incorporate patient marital status, tumor size, subtype, and radiotherapy history in assessments.
Recommend follow-up care to monitor for recurrence and manage side effects.
